Biotech · Private company

ORA, Inc.

Track this companyFree. Adds ORA, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials253 recruiting or active

Pipeline programs15From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline15

ST-100 (vezocolmitide)Phase 3 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
VehiclePhase 3 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
HPMCPhase 2 · Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
Ketorolac/HPMCPhase 2 · Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
PatanolPhase 2 · Allergic ConjunctivitisClinicalTrials.gov · fetched Nov 12, 2026
Pred-fortePhase 2 · Allergic ConjunctivitisClinicalTrials.gov · fetched Nov 12, 2026
PRT-2761 0.5%Phase 2 · Allergic ConjunctivitisClinicalTrials.gov · fetched Nov 12, 2026
PRT-2761 0%Phase 2 · Allergic ConjunctivitisClinicalTrials.gov · fetched Nov 12, 2026
PRT-2761 1%Phase 2 · Allergic ConjunctivitisClinicalTrials.gov · fetched Nov 12, 2026
TOP1630 Ophthalmic SolutionPhase 2 · Dry Eye SyndromeClinicalTrials.gov · fetched Nov 12, 2026
VehiclePhase 2 · Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
30-Day Bausch + Lomb PureVision (balafilcon A)Contact Lens ComplicationClinicalTrials.gov · fetched Nov 12, 2026
Acuvue® Oasys® Lenses (senofilcon A)Contact Lens ComplicationClinicalTrials.gov · fetched Nov 12, 2026
Clariti® 1-Day (Somofilcon A)Contact Lens ComplicationClinicalTrials.gov · fetched Nov 12, 2026
Visual Function TestsAge Related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials25

AT ELANA 841P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract RemovalNA · COMPLETED · started Jul 12, 2024ClinicalTrials.gov NCT06264232 · fetched Nov 12, 2026
A Phase 3 Study to Evaluate AZR-MD-001 in Patients with Abnormal Meibomian Gland Function and Dry Eye Disease (DED)PHASE3 · UNKNOWN · started May 28, 2024ClinicalTrials.gov NCT06329791 · fetched Nov 12, 2026
Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED)PHASE3 · UNKNOWN · started Dec 29, 2023ClinicalTrials.gov NCT06178679 · fetched Nov 12, 2026
Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye DiseasePHASE2 · COMPLETED · started Nov 29, 2023ClinicalTrials.gov NCT05896670 · fetched Nov 12, 2026
NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular DegenerationPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Sep 8, 2023ClinicalTrials.gov NCT05984927 · fetched Nov 12, 2026
Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With PresbyopiaPHASE1 · COMPLETED · started Jul 6, 2023ClinicalTrials.gov NCT05936489 · fetched Nov 12, 2026
The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye DiseasePHASE2 · COMPLETED · started Apr 28, 2023ClinicalTrials.gov NCT05759208 · fetched Nov 12, 2026
A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry EyePHASE3 · COMPLETED · started Jul 28, 2022ClinicalTrials.gov NCT05411367 · fetched Nov 12, 2026
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMDNA · RECRUITING · started Jun 16, 2022ClinicalTrials.gov NCT05438732 · fetched Nov 12, 2026
A Study of AG-80308 in Dry Eye PatientsPHASE1 · COMPLETED · started Jun 13, 2022ClinicalTrials.gov NCT05372107 · fetched Nov 12, 2026
Study of ST-100 as Treatment for Dry Eye DiseasePHASE2 · COMPLETED · started May 17, 2021ClinicalTrials.gov NCT05241470 · fetched Nov 12, 2026
Study of OT-101 in Treating MyopiaPHASE3 · ACTIVE_NOT_RECRUITING · started Apr 1, 2021ClinicalTrials.gov NCT04770610 · fetched Nov 12, 2026
Treatment Safety and Efficacy of Pro-ocular™ 1% for Chronic Ocular Graft Following Allogeneic HSCT.PHASE2 · COMPLETED · started Oct 17, 2019ClinicalTrials.gov NCT03990051 · fetched Nov 12, 2026
A Prospective Clinical Study to Evaluate the Repeatability of the Visibly Vision TestNA · COMPLETED · started Mar 4, 2019ClinicalTrials.gov NCT06812572 · fetched Nov 12, 2026
A Study to Evaluate AXR-159 Ophthalmic Solution in Patients With Dry Eye DiseasePHASE2 · COMPLETED · started Jun 26, 2018ClinicalTrials.gov NCT03598699 · fetched Nov 12, 2026
A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.PHASE3 · COMPLETED · started Apr 7, 2018ClinicalTrials.gov NCT03479307 · fetched Nov 12, 2026
A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and VehiclePHASE3 · COMPLETED · started Apr 7, 2018ClinicalTrials.gov NCT03489941 · fetched Nov 12, 2026
Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic ConjunctivitisPHASE2 · COMPLETED · started Oct 13, 2017ClinicalTrials.gov NCT03320434 · fetched Nov 12, 2026
Visual Function Tests in Age-related Macular DegenerationTERMINATED · started Sep 21, 2017ClinicalTrials.gov NCT03275753 · fetched Nov 12, 2026
A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® ModelPHASE2 · COMPLETED · started Jul 20, 2017ClinicalTrials.gov NCT03231969 · fetched Nov 12, 2026
Safety and Efficacy of TOP1630 for Dry Eye SyndromePHASE2 · COMPLETED · started Feb 20, 2017ClinicalTrials.gov NCT03088605 · fetched Nov 12, 2026
A Study of ADX-102 in Subjects With Allergic ConjunctivitisPHASE2 · COMPLETED · started Dec 1, 2016ClinicalTrials.gov NCT03012165 · fetched Nov 12, 2026
A Clinical Study Comparing the Comfort of Three Commercially Available Contact LensesNA · WITHDRAWN · started Aug 1, 2014ClinicalTrials.gov NCT02298400 · fetched Nov 12, 2026
Mucin Levels in Dry Eye and Normal PopulationsCOMPLETED · started May 1, 2013ClinicalTrials.gov NCT05911555 · fetched Nov 12, 2026
Efficacy Study of Ketorolac and HPMC to Treat Dry EyePHASE2 · WITHDRAWN · started Mar 1, 2009ClinicalTrials.gov NCT03693183 · fetched Nov 12, 2026